We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-8.74%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.03B
AUM Growth
-$97.2M
Cap. Flow
+$5.15M
Cap. Flow %
0.5%
Top 10 Hldgs %
54.98%
Holding
5,775
New
1,132
Increased
1,485
Reduced
1,487
Closed
1,545

Sector Composition

Rank Sector Weight
1 Financials 2.17%
2 Healthcare 1.69%
3 Industrials 1.67%
4 Technology 1.59%
5 Consumer Discretionary 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NATH icon
1926
Nathan's Famous
NATH
$402M
$16K ﹤0.01%
420
-522
-55% -$18K
NBHC icon
1927
National Bank Holdings
NBHC
$1.9B
$16K ﹤0.01%
770
-3,955
-84% -$81.8K
NBIX icon
1928
Neurocrine Biosciences
NBIX
$16.6B
$16K ﹤0.01%
397
-2,251
-85% -$109K
PLOW icon
1929
Douglas Dynamics
PLOW
$1.02B
$16K ﹤0.01%
+800
New +$17K
QUAD icon
1930
Quad
QUAD
$525M
$16K ﹤0.01%
1,294
+773
+148% +$11.7K
RDHL
1931
Redhill Biopharma
RDHL
$3.68M
$16K ﹤0.01%
+1
New +$14.8K
WAFD icon
1932
WaFd
WAFD
$2.75B
$16K ﹤0.01%
703
-2,720
-79% -$62.3K
WEYS icon
1933
Weyco Group
WEYS
$440M
$16K ﹤0.01%
580
+158
+37% +$4.4K
VIVS
1934
VivoSim Labs
VIVS
$1.64M
$16K ﹤0.01%
24
+12
+100% +$9.11K
NM
1935
DELISTED
Navios Maritime Holdings Inc.
NM
$16K ﹤0.01%
640
-370
-37% -$12.1K
SAL
1936
DELISTED
Salisbury Bancorp, Inc.
SAL
$16K ﹤0.01%
1,106
+584
+112% +$8.74K
EMCF
1937
DELISTED
Emclaire Financial Corp
EMCF
$16K ﹤0.01%
693
-646
-48% -$15.2K
CALA
1938
DELISTED
Calithera Biosciences, Inc
CALA
$16K ﹤0.01%
+148
New +$19.2K
XLNX
1939
DELISTED
Xilinx Inc
XLNX
$16K ﹤0.01%
+375
New +$15.8K
KIN
1940
DELISTED
Kindred Biosciences, Inc.
KIN
$16K ﹤0.01%
3,043
+690
+29% +$4.25K
MCEP
1941
DELISTED
Mid-Con Energy Partners, LP
MCEP
$16K ﹤0.01%
381
+349
+1,091% +$21.6K
ZBIO
1942
DELISTED
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
$16K ﹤0.01%
+236
New +$10.7K
GWR
1943
DELISTED
Genesee & Wyoming Inc.
GWR
$16K ﹤0.01%
267
+67
+34% +$4.62K
ZAIS
1944
DELISTED
ZAIS Group Holdings, Inc.
ZAIS
$16K ﹤0.01%
1,693
+1,295
+325% +$11.7K
BSJH
1945
DELISTED
Guggenheim BulletShares 2017 High Yield Corporate Bond ETF
BSJH
$16K ﹤0.01%
+630
New +$16.4K
TERP
1946
DELISTED
TerraForm Power, Inc
TERP
$16K ﹤0.01%
1,150
-2,338
-67% -$62.6K
CRDT
1947
DELISTED
WisdomTree Trust WisdomTree Strategic Corporate Bond Fund
CRDT
$16K ﹤0.01%
221
+102
+86% +$7.45K
CNV
1948
DELISTED
CNOVA N.V.
CNV
$16K ﹤0.01%
+5,292
New +$24.7K
FCLF
1949
DELISTED
FIRST CLOVER LEAF FINANCIAL CORP COM STK
FCLF
$16K ﹤0.01%
1,653
+1,371
+486% +$12.6K
EGPT
1950
DELISTED
VanEck Egypt Index ETF
EGPT
$16K ﹤0.01%
401
-166
-29% -$7.06K

Similar funds

Tower Research Capital (TRC)'s Q3 2015 Portfolio in Review

As of Q3 2015, Tower Research Capital (TRC) held 5,775 positions worth $1.03B, down 8.6% from $1.13B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC)'s Q3 2015 filing shows 1,132 new, 1,485 increased, 1,487 reduced and 1,545 closed positions. Its largest new stake was iShares Russell 2000 ETF: 144,546 shares worth $15.8M. The largest sale was VanEck Semiconductor ETF, an estimated $34M.

By sector, the portfolio is most concentrated in Financials at 2.2% of assets, down from 2.5% a quarter earlier, followed by Healthcare and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2015 buy was iShares Russell 2000 ETF: 144,546 shares worth $15.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q3 2015, an estimated $37.1M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2015 reduction was VanEck Semiconductor ETF, cutting an estimated $34M.
  • Tower Research Capital (TRC) fully exited Vanguard Extended Market ETF in Q3 2015, selling an estimated $10M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.03B portfolio in Q3 2015.
  • Tower Research Capital (TRC) opened 1,132 new positions and closed 1,545 in Q3 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 8.6% quarter-over-quarter to $1.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2015, filed 13 Nov 2015.